BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19131783)

  • 1. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N; Mialou V; Kebaïli K; Galambrun C; Bertrand Y; Pondarre C
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):928-30. PubMed ID: 19131783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
    Hannema SE; Brand A; van Meurs A; Smiers FJ
    Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M; Heidemann SM; Sarnaik AP; Meert KL; Sarnaik SA
    J Pediatr Hematol Oncol; 1999; 21(1):70-3. PubMed ID: 10029818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR; Patel AR
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP; Ataga KI
    Am J Med Sci; 2010 Mar; 339(3):266-9. PubMed ID: 20051821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S; Glasser CL
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review.
    Win N; Sinha S; Lee E; Mills W
    Transfus Med Rev; 2010 Jan; 24(1):64-7. PubMed ID: 19962576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient.
    Delmonte L; Cantini M; Olivieri O; De Franceschi L
    Transfusion; 2013 Mar; 53(3):688-9. PubMed ID: 23473065
    [No Abstract]   [Full Text] [Related]  

  • 13. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    McGlennan AP; Grundy EM
    Anaesthesia; 2005 Jun; 60(6):609-12. PubMed ID: 15918834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
    Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
    J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
    Dean CL; Maier CL; Roback JD; Stowell SR
    Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD; Williams ME
    Ann Clin Lab Sci; 1986; 16(3):214-8. PubMed ID: 3717883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.